Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 18/2013

Content (9 Articles)

Acknowledgement to Referees

  • Acknowledgement to Referees

Should Mild COPD Be Treated? Evidence for Early Pharmacological Intervention

  • Current Opinion

Amany F. Elbehairy, Katherine A. Webb, J. Alberto Neder, Denis E. O’Donnell

Critical Appraisal of Ramucirumab (IMC-1121B) for Cancer Treatment: From Benchside to Clinical Use

  • Leading Article

Giuseppe Aprile, Marta Bonotto, Elena Ongaro, Carmelo Pozzo, Francesco Giuliani

Promoting Remyelination in Multiple Sclerosis—Recent Advances

  • Open Access
  • Review Article

E. Jolanda Münzel, Anna Williams

Crizotinib: A Review of Its Use in the Treatment of Anaplastic Lymphoma Kinase-Positive, Advanced Non-Small Cell Lung Cancer

  • Adis Drug Evaluation

James E. Frampton

Eculizumab: A Review of Its Use in Atypical Haemolytic Uraemic Syndrome

  • Adis Drug Evaluation

Gillian M. Keating

Modified-Release Prednisone: in Patients with Rheumatoid Arthritis

  • Adis Drug Evaluation

Sheridan Henness, Lily P. H. Yang

Abiraterone Acetate: A Review of Its Use in Patients with Metastatic Castration-Resistant Prostate Cancer

  • Adis Drug Evaluation

Sheridan M. Hoy

Simeprevir: First Global Approval

  • R&D Insight Report

Asha Vaidya, Caroline M. Perry

Nov 13
Issue: 17/2013
Jan 14
Issue: 1/2014

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images